SI c.419G>C ;(p.G140A)

Variant ID: 3-164786574-C-G

NM_001041.3(SI):c.419G>C;(p.G140A)

This variant was identified in 3 publications

View GRCh38 version.




Publications:


Integrative proteomic characterization of adenocarcinoma of esophagogastric junction.

Nature Communications
Li, Shengli S; Yuan, Li L; Xu, Zhi-Yuan ZY; Xu, Jing-Li JL; Chen, Gui-Ping GP; Guan, Xiaoqing X; Pan, Guang-Zhao GZ; Hu, Can C; Dong, Jinyun J; Du, Yi-An YA; Yang, Li-Tao LT; Ni, Mao-Wei MW; Jiang, Rui-Bin RB; Zhu, Xiu X; Lv, Hang H; Xu, Han-Dong HD; Zhang, Sheng-Jie SJ; Qin, Jiang-Jiang JJ; Cheng, Xiang-Dong XD
Publication Date: 2023-02-11

Variant appearance in text: SI: 419G>C; Gly140Ala
PubMed Link: 36774361
Variant Present in the following documents:
  • 41467_2023_36462_MOESM5_ESM.xlsx, sheet 1
View BVdb publication page



4-amino-1-hydroxy-2-oxo-1,8-naphthyridine-containing compounds having high potency against raltegravir-resistant integrase mutants of HIV-1.

Journal Of Medicinal Chemistry
Zhao, Xue Zhi XZ; Smith, Steven J SJ; Métifiot, Mathieu M; Marchand, Christophe C; Boyer, Paul L PL; Pommier, Yves Y; Hughes, Stephen H SH; Burke, Terrence R TR
Publication Date: 2014-06-26

Variant appearance in text: SI: G140A
PubMed Link: 24901667
Variant Present in the following documents:
  • Main text
  • jm5001908.pdf
View BVdb publication page



Bicyclic 1-hydroxy-2-oxo-1,2-dihydropyridine-3-carboxamide-containing HIV-1 integrase inhibitors having high antiviral potency against cells harboring raltegravir-resistant integrase mutants.

Journal Of Medicinal Chemistry
Zhao, Xue Zhi XZ; Smith, Steven J SJ; Métifiot, Mathieu M; Johnson, Barry C BC; Marchand, Christophe C; Pommier, Yves Y; Hughes, Stephen H SH; Burke, Terrence R TR
Publication Date: 2014-02-27

Variant appearance in text: SI: G140A
PubMed Link: 24471816
Variant Present in the following documents:
  • Main text
  • jm401902n.pdf
View BVdb publication page